Junichi Mochida
Overview
Explore the profile of Junichi Mochida including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
32
Citations
93
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Hashimoto S, Obinata D, Uchida H, Arakawa S, Inagaki Y, Nakahara K, et al.
BJUI Compass
. 2025 Mar;
6(3):e70001.
PMID: 40046106
Objective: To assess the impact of preoperative pelvic floor muscle thickness on the early recovery of urinary continence following robot-assisted radical prostatectomy (RARP). Patients And Methods: A retrospective study was...
2.
Obinata D, Hara M, Hashimoto S, Nakahara K, Yoshizawa T, Mochida J, et al.
Int Urogynecol J
. 2024 Aug;
35(9):1889-1898.
PMID: 39186089
Introduction And Hypothesis: This study evaluated the association between pelvic organ prolapse (POP), frailty, and sarcopenia to explore how POP treatment can extend healthy life expectancy in elderly women. Methods:...
3.
Uehara R, Obinata D, Hashimoto S, Nakahara K, Uchida H, Yoshizawa T, et al.
Medicine (Baltimore)
. 2024 Mar;
103(9):e37371.
PMID: 38428891
Background: A new subtype of prostate cancer called treatment-related neuroendocrine prostate carcinoma (t-NEPC) was added to the revised World Health Organization classification of prostate cancer in 2022. t-NEPC cases are...
4.
Obinata D, Mochida J, Uehara R, Osawa M, Hashimoto S, Nakahara K, et al.
Medicine (Baltimore)
. 2023 Nov;
102(46):e36055.
PMID: 37986385
Benign prostatic hyperplasia (BPH) is prevalent in older men. As surgery can be high risk in this group, minimally invasive procedures are preferrable. This study aimed to assess the initial...
5.
Obinata D, Uehara R, Hashimoto S, Nakahara K, Yoshizawa T, Mochida J, et al.
BMC Urol
. 2023 Nov;
23(1):188.
PMID: 37980529
Background: This study aimed to assess initial results and patient characteristics of prostatic urethral lift (PUL) compared with those of bipolar transurethral enucleation of the prostate (TUEB) in the treatment...
6.
Uchida H, Obinata D, Takada S, Yoshizawa T, Mochida J, Yamaguchi K, et al.
J Int Med Res
. 2023 May;
51(5):3000605231173319.
PMID: 37226460
Objective: To compare estimated survival times of patients who had received maintenance monotherapy with gemcitabine (GEM), or an immuno-oncology (IO) drug (i.e., pembrolizumab or avelumab) or both therapies (one after...
7.
Obinata D, Hashimoto S, Uchida H, Nakahara K, Yoshizawa T, Mochida J, et al.
BMC Urol
. 2023 Apr;
23(1):74.
PMID: 37118708
Background: Although the second-generation androgen receptor inhibitors and taxanes have recently been recommended for the initial treatment of metastatic prostate cancer, bicalutamide and flutamide are still used in a large...
8.
Obinata D, Nakahara K, Yoshizawa T, Mochida J, Yamaguchi K, Takahashi S
Medicine (Baltimore)
. 2022 Nov;
101(44):e31658.
PMID: 36343082
We performed a retrospective study to clarify the characteristics of prostate biopsies in patients treated with dutasteride, a benign prostate hyperplasia treatment drug that inhibits 5α-reductase. We studied the digital...
9.
Obinata D, Funakoshi D, Sakurai F, Yoshizawa T, Mochida J, Yamaguchi K, et al.
Medicine (Baltimore)
. 2022 Aug;
101(32):e29510.
PMID: 35960101
This study aimed to clarify the real-world efficacy of sequential nivolumab for treating metastatic renal cancer after first-line molecular targeting therapy. Patients were divided into two groups (2014-2016 and 2017-2020)...
10.
Obinata D, Yamaguchi K, Hashimoto S, Yoshizawa T, Mochida J, Takahashi S
J Int Med Res
. 2022 Jun;
50(6):3000605221106434.
PMID: 35734995
Objective: We aimed to evaluate the mid-term efficacy of tension-free vaginal mesh (TVM) for pelvic organ prolapse (POP), and observe the time course of lower urinary tract symptoms and sexual...